Volume 2, Issue 3 | March 2024
MAYO CLINIC TECHNOLOGY SNAPSHOT
Mayo Clinic Ventures, the commercialization arm within Business Development, is continually seeking partners and strategic collaborators to bring innovative technologies to market.

Below is a small sampling of select technologies available for licensing.
OSAIL initiative

Mayo Clinic’s Orthopedic Surgery Artificial Intelligence Laboratory (OSAIL) has developed a generative AI model to predict and visualize the outcomes of various surgical approaches in hip and knee arthroplasty. The model can analyze a patient’s condition and generate proposed outcomes to various treatments, enabling increased understanding of procedure options and considerations prior to surgery.
Alpha-PET

Innovators at Mayo Clinic have created the Alpha-PET oncological platform. This system can image and treat cancer using only a single compound, leading to simpler treatments, clearer tracking of results, and enhanced patient outcomes. Mayo Clinic Ventures is actively seeking an industry collaborator to exclusively license this novel imaging and therapy technology.
Advancing healthcare through collaborative efforts

Mayo Clinic researchers and innovators submit hundreds of invention disclosures each year, and Business Development staff are looking for collaborators to bring these novel technologies to market.

Read about a few noteworthy examples >
Learn more about licensing Mayo Clinic technology
RECENT NEWS
Spotlight on early detection of 3 heart diseases using ECG-AI

Mayo Clinic News Network | February 22, 2024

Mayo Clinic has developed ECG-AI algorithms that are currently used in research to predict a patient's likelihood of having various heart conditions.
Read article
Bionaut Labs raises an extension round in preparation for micro-robot clinical trials

Fortune | February 6, 2024

Mayo Clinic is collaborating with Bionaut Labs to develop a minimally invasive micro-robot with the initial goal of treating Dandy-Walker Syndrome, which causes fluid to accumulate in the brain. 
Read article
Exhalation Technology announces collaboration with Mayo Clinic to develop PoC test

EIN Newsdesk | February 6, 2024

Exhalation Technology announced a know-how agreement with Mayo Clinic to develop a diagnostic test to detect and distinguish between bacterial and viral pneumonia.
Read article
Mayo Clinic is helping develop a tool providers can use to curb clinical bias

Med City News | February 4, 2024

Mayo Clinic is collaborating with Phoenix-based startup TruLite Health to develop its software platform designed to address providers’ clinical bias. 
Read article
EVENTS
RAEDI leads and supports economic, community, and workforce development initiatives that grow and diversify the greater Rochester, Minnesota area economy.

Mayo Clinic is a proud sponsor of this event.
Find Business Development staff at these upcoming conferences:
JOB OPENINGS
  • Technology Licensing Associate
  • Technology Development Associate, Biopharma
  • Technology Development Associate, Radiology/Imaging
  • Corporate Development Manager, Contracts
About Business Development
Business Development is Mayo Clinic’s front door to business – from technology commercialization to strategic partnerships – catalyzing innovation to shape the future of healthcare for the benefit of patients.

The department's two divisions, Mayo Clinic Ventures and Corporate Development, come together as one unified force to bridge the gaps between industry and commercial groups to produce meaningful, effective changes in transforming health and medicine.
Subscribe to receive updates directly.
Mayo Clinic 200 First St. SW | Rochester, MN 55905
Copyright 2024 Mayo Foundation for Medical Education and Research. All rights reserved.
Customer Service | MayoClinic.org

Terms and Conditions of Use | Privacy Policy